Takeda Pharma Divests Yet Another Non-Core Asset to Pay-Off Debt and Focus on Core Areas
On 24th April, Takeda Pharmaceutical announced that it has entered into an agreement to sell off a portfolio of select non-core over the counter...
392 Views
More Covering on Consumer Staples and Discretionary
The short notional in the market for the data released 28 April is US$33.44bn (down by US$62mm excluding FX movements and ETFs) with the largest...
304 Views
J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways
In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...
339 Views
Japan’s Astellas Pharma Buys US-Based Xyphos Biosciences Inc.
It was reported by Reuters and several other media that the Japan-based Astellas Pharma has bought the US-based Xyphos Bioscience Inc. in a deal...
532 Views
Japan’s Astellas Pharma to Buy Audentes Therapeutics to Expand into Gene Therapy Market
It was reported by Reuters and several other media that the Japan-based Astellas Pharma has agreed to buy the US-based Audentes Therapeutics for...
429 Views